Tenvir-AF (Tenofovir Alafenamide)

Overview

Tenvir-AF is an antiretroviral drug with an active substance called Tenofovir Alafenamide (TAF). It is used in treatments for HIV-1 infections as well as chronic Hepatitis B virus (HBV) infection. Tenofovir Alafenamide is part of the category of nucleotide reverse transcriptase inhibitors (NRTIs). It is a drug that blocks the function of reverse transcriptase which is an enzyme that plays a crucial role in reproducibility of HIV as well as HBV.

Tenofovir Alafenamide is a newer prodrug of tenofovir that offers enhanced delivery of the active drug into target cells with significantly lower systemic exposure, resulting in improved safety profiles—particularly reduced kidney toxicity and bone mineral density loss—compared to its predecessor, Tenofovir Disoproxil Fumarate (TDF).

Composition

Each tablet of Tenvir-AF contains:

• Tenofovir Alafenamide Fumarate — 25 mg (equivalent to 25 mg of Tenofovir Alafenamide)

Inactive ingredients are the microcrystalline form of cellulose as well as croscarmellose sodium magnesium stearate and other that aid in the formulation of tablets and absorption.

Mechanism of Action

Tenofovir Alafenamide is an protodrug that is converted intracellularly into its active compound tenofovir diphosphate that inhibits reverse transcriptase enzyme. Through mimicking the nature-based substrates for reverse transcriptase, the tenofovir is integrated into viral DNA chains, and triggers the termination prematurely of DNA synthesizing.

The inhibition blocks the replication of viruses, thus reducing the amount of virus and enhancing performance of the immune system in those by HIV and HBV.

Indications

• HIV-1 Infection: It is used as a component of antiretroviral treatment (ART) for treatment of HIV-1 infections in adults and children aged 12 years or older and who weigh at least 35kg.
• Chronic Hepatitis B: It is recommended for treatment of chronic HBV infection for adults as well as adolescents 12 years old and over weighing less than 35kg.

Dosage and Administration

• The recommended dose for Tenvir-AF will be 25 mg, orally twice every day in combination whether or not food is consumed.
• It is best to consider it one of the components of an overall antiretroviral treatment regimen to treat HIV.
• In the case of persistent HBV infection, monotherapy with Tenvir-AF is usually prescribed.
• Tablets should be consumed as a whole, and not chewed crushed or broken.
• Adjustments to dosages may be required for patients suffering from renal impairment. Consulting the healthcare professional is vital.
• Duration of treatment is dependent on the response of patients and suppression of viral.

Contraindications

• Hypersensitivity to Tenofovir Alafenamide, or any ingredient in the composition.
• The co-administration of other medications containing Tenofovir, or other NRTIs with toxic overlaps, as long as it is not directed by a physician.

Warnings and Precautions

• Renal Toxicity: Even though Tenofovir Alafenamide has been connected with less renal toxicity in comparison to Tenofovir Disoproxil monitoring kidney function is suggested.
• Bone Mineral Density: The patient should be evaluated for any possible declines in the bone mineral density.
• Lactic Acidosis and Severe Hepatomegaly: Some rare cases have been identified by NRTI users.
• Hepatitis B Reactivation: In patients with HBV, abrupt discontinuation can result in an acute and severe exacerbation. Careful monitors are required.
• Drug Interactions: Avoid using drugs that interfere with the function of your kidney or cause nephrotoxicity.
• Pregnancy and Lactation: Make use of only when clearly required and under the supervision of a physician.
• Resistance: Drug-resistant HIV or HBV strains are a possibility; it is important to adhere to the treatment.

Side Effects

Common Side Effects:

• Nausea
• Headache
• Fatigue
• Abdominal pain
• Diarrhea
• Dizziness

Less Common Side Effects:

• Elevated liver enzymes (ALT, AST)
• Rash
• Insomnia

Serious Side Effects (Rare):

• Renal impairment
• Lactic acidosis
• Severe hypersensitivity reactions

Any patients who experience unusual symptoms immediately, particularly signs of an allergic reaction or extreme fatigue.

Drug Interactions

• P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP) Inhibitors: Could increase Tenofovir levels.
• CYP3A4 Inducers (e.g., rifampin, carbamazepine): May reduce Tenofovir Alafenamide efficacy.
• Other Nephrotoxic Drugs: Risk of kidney impairment increases and monitoring the kidney’s function.
• The antiretroviral regimen should be controlled by medical professionals in order to avoid interactions.

Use in Special Populations

• Pregnant Women: Available data is limited Use only when the benefit is greater than the risk.
• Pediatric Use: Accepted by children 12 years and over who weigh at least 35kg.
• Elderly: Aucune dosage specific adjustment is required, however be sure to monitor the function of your kidneys.
• Renal Impairment: Adjusting dose or monitoring closely is necessary in cases of moderate or severe impairment.

Storage

• Keep at room temperature and store, preferring between 20°C and 25°C.
• Protect from moisture and direct sunlight.
• Be sure to keep away from young children.

FAQs (Frequently Asked Questions)

What is Tenvir-AF used for?

It’s used to treat HIV-1 infections in combination therapy as well as chronic the hepatitis B condition.

How do I take Tenvir-AF?

Consume one tablet (25 mg) every day, orally whether or not you eat, according to the prescription.

Can I take Tenvir-AF with other HIV medications?

Yes, It is designed as a as part of a combined antiretroviral treatment. Be sure to follow the advice of your physician guidelines.

What should I do if I miss a dose?

Do not miss the dose until whenever you remember or if it’s close to the time of your next dose. Don’t double-dose.

Are there any common side effects?

Fatigue, nausea, headache as well as abdominal pain are not uncommon. See your physician if any symptoms are serious.

Can Tenvir-AF cause kidney problems?

It’s less harmful to kidneys than older formulations however the kidney’s function must be checked.

Is Tenvir-AF safe during pregnancy?

There is limited information available. Make use of only in cases where it is clearly necessary and in conjunction with a physician’s supervision.

What happens if I stop taking Tenvir-AF suddenly?

The abrupt stopping of treatment, particularly in hepatitis B patients, can result in a serious flare-up of liver disease. Consult your doctor before stopping.

Can I drink alcohol while on Tenvir-AF?

The alcohol consumption can cause liver issues to worsen. You should discuss your drinking alcohol with your medical physician.

How should I store Tenvir-AF?

Place the items in a cool and dry location far from direct sunlight, and away from children’s reach.

Summary

Tenvir-AF (Tenofovir Alafenamide) is an effective, modern oral antiviral medicine used for treatments for HIV-1 as well as chronic Hepatitis B diseases. It is more secure especially in relation to bone and kidney health in comparison to previous tenofovir formulations. If taken once a day Tenvir-AF inhibits the replication of viruses through the inhibition of reverse transcriptase which improves immune function, as well as reducing the load of viral.

Monitoring of the renal function regularly along with liver enzymes as well as the compliance to therapy are crucial to make sure that the treatment is effective and avoid adverse negative effects. Patients should not abruptly stop treatment especially if they are infected with the hepatitis B because of the risk of serious complications.

Tenvir-AF is a vital element of the modern antiviral treatment that has a positive efficacy and the safety profile to help people with chronic viral infections efficiently.